{"SPADE_N_14915": {"Sequence Information": {"Peptide Name": "Mojavensin A", "Sequence": "XNYNQPNN", "Sequence Length": 8, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Bacillus mojavensis B0621A\n2. Gordonia terrae WA 4-31", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Antimicrobial compounds were isolated from the secondary metabolites of Gordonia, a resident of intestinal tract of Periplaneta americana", "Pubmed ID": "34331149", "Reference": "AMB Express. 2021;11:111", "Author": "Ma Y, Xu M, Liu H, Yu T, Guo P, Liu W, Jin X", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/34331149"}, {"Title": "Isolation and characterization of a new iturinic lipopeptide, mojavensin A produced by a marine-derived bacterium Bacillus mojavensis B0621A", "Pubmed ID": "22491138", "Reference": "J Antibiot (Tokyo). 2012;65:317-322", "Author": "Ma Z, Wang N, Hu J, Wang S", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/22491138"}], "SPADE ID": "SPADE_N_14915", "Similar Sequences": [{"SPADE_ID": "SPADE_N_07213", "Similarity": 1.0, "Sequence": "NNNYNQP"}, {"SPADE_ID": "SPADE_N_07386", "Similarity": 0.8571428571428571, "Sequence": "NYNQPNS"}, {"SPADE_ID": "SPADE_N_14916", "Similarity": 0.8571428571428571, "Sequence": "NYNQPNS"}], "Hemolytic Activity": "", "Target Organism": "Candida albicans ATCC 10231(MIC=64µg/ml),Trichophyton rubrum ATCC 60836(MIC=16µg/ml),Aspergillus niger ATCC 16404(MIC=32µg/ml),Aspergillus fumigatus ATCC 96918(MIC=64µg/ml),Staphylococcus aureus ATCC 43300(MIC=>256µg/ml),Staphylococcus aureus ATCC 25923(MIC=>256µg/ml),Escherichia coli ATCC 25922(MIC=32µg/ml),Klebsiella pneumoniae ATCC 13883(MIC=>256µg/ml),Human hepatocellular carcinoma HepG2(20-30% Cytotoxicity=50µg/ml),Human nasopharyngeal carcinoma CNE2(60-70% Cytotoxicity=50µg/ml),Human promyelocytic leukemia HL-60(IC50=100µM)"}}}